Data: Airfinity; Chart by Andrew Witherspoon / Akios
The Biden administration has taken its biggest step into becoming a global supplier of coronavirus vaccines, announcing that it will export 60 million doses of AstraZeneca over the next few weeks.
Why is it possible? President Biden was under global control for his “Americans first” approach. Of the four major producers alone, the United States has so far maintained almost all of its supplies.
Stay on top of the latest market trends and economic insights through Axios Markets. Subscribe for free
The biggest symbol of Washington’s “vaccine nationalism” has been the accumulation of the AstraZeneca vaccine, which has not been approved in the United States – it is not necessary, but it is crucial for many countries.
A senior administration official told reporters tonight that only 10 million doses are expected to be distributed (much lower than previously reported), while “50 million doses will be ready by June”.
These portions will be exported Around the world, waiting for an FDA security check, but the White House says no decision has been made as to which countries will receive them.
India may be at the top of the list, given the horrific outbreak there, although the White House says Prime Minister Narendra Modi did not call for quotas with Biden today.
The same could be true of Mexico, which has turned to Russia and China for vaccines, even though it shares a border with one of the world’s largest producers.
Note: This map shows the total number of vaccines given, not the number of people vaccinated. Data. Our world of data; Map of Daniel Alberti / Akios
Breaking it Despite the relatively small, 231 million doses that the United States has already taken, the 60 million doses will be a major boost to a very tight global supply.
COVAX, the main source of vaccines for dozens of low-income countries, has so far distributed only 45 million doses worldwide.
Even now, when Biden has shown that he is ready to export the vaccines to the United States no using, obviously the next question: when will he allow to export his Pfizer, Moderna և Johnson & Johnson?
What to watch? Almost everyone in the United States who wants the vaccine will probably have it in the next two to three weeks, according to Axios’ Caitlin Owens.
And when demand begins to weaken, supply must continue to grow. Pfizer, Moderna, J&J և AstraZeneca still owe the US hundreds of millions of shares (more if Biden makes additional purchases).
Biden will face international pressure և public health imperatives to share those doses with the world. He said he hoped the United States would have a “surplus” but did not specify what the surplus would be or where the doses would go.
From one side: The Biden administration stressed the need for caution, flexibility at home, noting possible production disruptions, the possibility of amplifying shots, and the possibility of vaccinating children.
On the other hand , Secretary of State Tony Blinken has said the United States will be “the world leader in helping to ensure that the whole world is vaccinated.”
Inner line. Even when the United States spends billions of dollars on that goal, he did not want to use Biden’s biggest asset. Doses coming out of US factories every week.
More from Axios. Sign up for the latest market trends with Axios Markets. Subscribe for free